Honey and Nigella Sativa in COVID-19 Prophylaxis

• Status: Recruiting
• Trial end date: 2022-04-15
• Target enrollment: 0
• Participant gender: All

Summary

Honey and Nigella sativa has established antiviral, antibacterial, anti-inflammatory, and immunomodulatory roles. So it is planned to test for its prophylaxis

• Phase: Phase 2/Phase 3
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Sohaib Ashraf

Criteria

Inclusion Criteria:

• Health care professionals Post-exposure COVID-19

Exclusion Criteria:

• Multi-organ failure active COVID-19